Navigation Links
Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B

Genetically modified tomatoes that contain edible vaccine could be used against two of the world's most lethal viruses namely HIV and hepatitis B//.

Researchers have declared that it would be possible to create cheap vaccines that could be grown and processed in poorer countries where there is a very large need but no funds available to produce the existing vaccines.

It was reported that Rurik Salyaev, of the Siberian Institute of Plant Physiology in Russia, in his research placed DNA from both viruses into tomatoes. Experimental mice were found to have developed high levels of antibodies against the viruses even on body surfaces where viruses can gain entry through sexual contact, when they were fed with a solution containing the powdered tomatoes. The researchers hope that eventually the vaccine could be given orally as tablets, eliminating the need for injections.

Rose Hammond, of the US Department of Agriculture Research Service, which is also collaborating with the research said, 'You wouldn't have to refrigerate the vaccine and wouldn't need to inject it with needles, which pose an infection risk. These would be big advantages in poor countries.'


'"/>




Page: 1

Related medicine news :

1. Cipro Has Cheaper Cousins to Treat Anthrax
2. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
3. Diabetics to get Relief from Cheaper Drugs
4. Cheaper and Quicker Alternative to Ovarian Reserve Tests
5. Producing Vaccines from genetically modified crops
6. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
7. New Anthrax Vaccines Will Take time
8. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
9. Health and Human Services stockpiles 20 million bird flu Vaccines
10. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
11. Oral Edible vaccine for Allergy Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: